Merck KGaA (MKGAF) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free MKGAF Stock Alerts $180.00 -2.50 (-1.37%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Merck KGaA Stock Price Performance5 Day Performance+4.16%1 Month Performance+15.38%3 Month Performance+5.88%6 Month Performance+7.14%Year-To-Date Performance+11.80%1 Year Performance-0.90% Receive MKGAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsForget Bitcoin: This $8 Stock Is the Next Big Thing4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> MKGAF Stock Chart for Sunday, May, 19, 2024 MKGAF Chart by TradingView Merck KGaA Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$182.50$180.00-1.37%$185.50$178.58261 shs$23.26 billion05/16/2024$175.59$182.50+3.93%$182.57$181.46757 shs$23.59 billion05/15/2024$172.81$175.59+1.61%$178.46$175.59290 shs$22.69 billion05/14/2024$164.31$172.81+5.18%$172.81$168.75176 shs$22.33 billion05/13/2024$168.35$164.31-2.40%$168.46$164.3142 shs$21.23 billion05/10/2024$165.43$168.35+1.76%$168.35$166.252,003 shs$21.76 billion Get the Latest News and Ratings for MKGAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$165.15$165.43+0.17%$165.43$165.431 shs$21.38 billion05/08/2024$168.78$165.15-2.15%$166.54$165.15183 shs$21.34 billion05/07/2024$162.75$168.78+3.71%$168.78$168.781 shs$21.81 billion05/06/2024$162.23$162.75+0.32%$166.56$160.73666 shs$21.03 billion05/03/2024$162.00$162.23+0.14%$165.97$161.8258 shs$20.97 billion05/02/2024$154.11$162.00+5.12%$163.20$158.41223 shs$20.94 billion05/01/2024$161.00$154.11-4.28%$162.15$154.1121 shs$19.92 billion04/30/2024$163.26$161.00-1.39%$162.29$161.0056 shs$20.81 billion04/29/2024$157.08$163.26+3.94%$163.26$160.0442 shs$21.10 billion04/26/2024$165.33$157.08-4.99%$166.52$157.0882 shs$20.30 billion04/25/2024$158.36$165.33+4.40%$165.33$154.801,092 shs$21.37 billion04/24/2024$160.51$158.36-1.33%$168.14$158.36111 shs$20.47 billion04/23/2024$156.00$160.51+2.89%$160.51$160.5118 shs$20.74 billion04/22/2024$156.00$156.00$156.00$152.0563 shs$20.16 billion04/19/2024$158.75$156.00-1.73%$156.04$154.32361 shs$20.16 billion04/18/2024$158.75$158.75$160.52$156.85313 shs$20.52 billion04/17/2024$162.38$158.75-2.24%$160.52$156.85313 shs$20.52 billion04/16/2024$162.00$162.38+0.24%$162.38$162.385 shs$20.99 billion04/15/2024$163.51$162.00-0.92%$163.69$158.98267 shs$20.94 billion04/12/2024$164.90$163.51-0.84%$163.75$161.78285 shs$21.13 billion04/11/2024$161.50$164.90+2.11%$164.90$161.9538 shs$21.31 billion04/10/2024$168.25$161.50-4.01%$162.63$160.80556 shs$20.87 billion04/09/2024$162.62$168.25+3.46%$168.25$165.10113 shs$21.74 billion04/08/2024$162.00$162.62+0.38%$166.63$162.6229 shs$21.02 billion04/05/2024$169.10$162.00-4.20%$167.90$160.57205 shs$20.94 billion04/04/2024$171.50$169.10-1.40%$170.60$169.10566 shs$21.85 billion04/03/2024$169.25$171.50+1.33%$173.19$169.4120,068 shs$22.16 billion04/02/2024$176.50$169.25-4.11%$169.25$169.2522 shs$21.87 billion04/01/2024$176.81$176.50-0.18%$180.43$172.94664 shs$22.81 billion03/29/2024$176.81$176.81$178.15$175.73617 shs$22.85 billion03/28/2024$174.23$176.81+1.48%$178.15$175.73617 shs$22.85 billion03/27/2024$172.45$174.23+1.03%$174.23$172.14437 shs$22.52 billion03/26/2024$173.13$172.45-0.39%$173.50$171.38448 shs$22.29 billion03/25/2024$171.24$173.13+1.10%$174.79$172.54208 shs$22.38 billionPOTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning.03/22/2024$175.50$171.24-2.43%$180.68$171.2497 shs$22.13 billion03/21/2024$168.18$175.50+4.35%$175.50$174.22199 shs$22.68 billion03/20/2024$171.00$168.18-1.65%$168.18$168.1831 shs$21.74 billion03/19/2024$170.50$171.00+0.29%$171.55$170.78390 shs$22.10 billion03/18/2024$174.86$170.50-2.49%$171.03$170.46346 shs$22.04 billion03/15/2024$173.50$174.86+0.78%$175.54$173.48176 shs$22.60 billion03/14/2024$175.72$173.50-1.26%$174.69$173.50474 shs$22.42 billion03/13/2024$176.00$175.72-0.16%$175.72$175.725,206 shs$22.71 billion03/12/2024$171.75$176.00+2.47%$176.00$174.94104 shs$22.75 billion03/11/2024$172.00$171.75-0.15%$171.75$169.03255 shs$22.20 billion03/08/2024$174.75$172.00-1.57%$173.00$172.00285 shs$22.23 billion03/07/2024$174.75$174.75$174.75$171.78128 shs$22.58 billion03/06/2024$173.20$174.75+0.89%$174.75$174.3842 shs$22.59 billion03/05/2024$173.50$173.20-0.17%$173.70$170.75165 shs$22.38 billion03/04/2024$173.00$173.50+0.29%$173.50$170.00176 shs$22.42 billion03/01/2024$170.00$173.00+1.76%$173.00$171.26350 shs$22.36 billion02/29/2024$171.03$170.00-0.60%$172.33$170.00590 shs$21.97 billion02/28/2024$171.00$171.03+0.01%$171.50$171.03594 shs$22.10 billion02/27/2024$170.00$171.00+0.59%$171.00$169.07132 shs$22.10 billion02/26/2024$170.03$170.00-0.01%$172.00$169.9992 shs$21.97 billion02/23/2024$170.00$170.03+0.01%$172.40$170.03177 shs$21.97 billion02/22/2024$166.10$170.00+2.35%$171.98$168.03397 shs$21.97 billion02/21/2024$168.50$166.10-1.42%$167.88$163.956,985 shs$21.47 billion02/20/2024$170.00$168.50-0.88%$168.50$164.0362 shs$21.78 billion02/19/2024$170.00$170.00$170.00$166.25500 shs$21.97 billion Related Companies: Alnylam Pharmaceuticals Stock Price Chart Genmab A/S Stock Price Chart Astellas Pharma Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart BeiGene Stock Price Chart Viatris Stock Price Chart Sarepta Therapeutics Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart United Therapeutics Stock Price Chart Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MKGAF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.